Table 2.
Clinical Characteristics and Preprocedural Antiplatelet/anticoagulant Agents (Mild Thrombocytopenia Group vs. Moderate Thrombocytopenia Group).
| Mild thrombocytopenia | Moderate thrombocytopenia | p | |
|---|---|---|---|
| n=187 | n=39 | ||
| Age (mean years±SD) | 74±9 | 73±7 | 0.738 |
| Male (%) | 144 (77.0) | 25 (64.1) | 0.091 |
| Platelets (×103/μL) | 131±13 | 81±13 | <0.001 |
| BMI (kg/m2) | 22.5±3.5 | 23.1±3.2 | 0.284 |
| Hypertension (%) | 144 (77.0) | 31 (79.5) | 0.736 |
| Diabetes mellitus (%) | 99 (52.9) | 21 (53.8) | 0.918 |
| Dyslipidemia (%) | 108 (57.8) | 29 (74.4) | 0.054 |
| Current smoking (%) | 22 (11.8) | 5 (12.8) | 0.853 |
| Hemodialysis (%) | 59 (31.6) | 14 (35.9) | 0.597 |
| Hb (g/dL) | 11.7±1.7 | 11.1±1.8 | 0.023 |
| PCI indication | |||
| Stable AP (%) | 68 (36.4) | 17 (43.6) | 0.206 |
| SMI (%) | 97 (51.9) | 21 (53.8) | |
| ACS (%) | 22 (11.8) | 1 (2.6) | |
| Preprocedural medication | |||
| Aspirin (%) | 154 (82.4) | 36 (92.3) | 0.122 |
| Thienopiridine (%) | 132 (70.6) | 33 (84.6) | 0.073 |
| DAPT (%) | 120 (64.2) | 32 (82.1) | 0.030 |
| Anticoagulant (%) | 26 (13.9) | 6 (15.4) | 0.809 |
| Triple therapy (%) | 14 (7.5) | 6 (15.4) | 0.114 |
BMI: body mass index, Hb: hemoglobin, PCI: percutaneous coronary intervention, AP: angina pectoris, SMI: silent myocardial ischemia, ACS: acute coronary syndrome, DAPT: dual antiplatelet therapy